Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ARI B GELLER

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1710927892
CMS profile
213281
Location
BLOOMFIELD, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$82,944.32

106 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ARI B GELLER

NPI 1710927892 · CMS profile ID 213281

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

BLOOMFIELD, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1710927892?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ARI B GELLER, NPI 1710927892, CMS profile ID 213281. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1710927892?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ARI B GELLER, NPI 1710927892, CMS profile ID 213281. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1710927892?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ARI B GELLER, NPI 1710927892, CMS profile ID 213281, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1710927892?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

106 matching records · $82,944.32 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 106 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–106 of 106.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AKEBIA THERAPEUTICS INC $1,430.0001/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1241830165 CMS
AKEBIA THERAPEUTICS INC $572.0001/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1241830167 CMS
Travere Therapeutics, Inc. $0.3701/13/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1244433681 CMS
AKEBIA THERAPEUTICS INC $21.6201/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241830565 CMS
AKEBIA THERAPEUTICS INC $13.3001/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241830567 CMS
AKEBIA THERAPEUTICS INC $25.0001/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241830569 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $15,194.45 34
PY2020 $7,685.68 16
PY2021 $4,343.34 9
PY2022 $18,034.53 27
PY2023 $18,291.56 31
PY2024 $62,981.29 79
PY2025 $82,944.32 106

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $74,597.00 103
PY2024 Principal investigator $65,663.95 3
PY2023 Principal investigator $14,359.07 2
PY2022 Principal investigator $112,750.15 4
PY2021 Principal investigator $9,665.22 13
PY2020 Principal investigator $11,419.36 7
PY2019 Principal investigator $27,960.28 56

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

103 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AKEBIA THERAPEUTICS INC $216.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841617
Principal investigator 1 AKEBIA THERAPEUTICS INC $917.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841669
Principal investigator 1 AKEBIA THERAPEUTICS INC $917.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841671
Principal investigator 1 AKEBIA THERAPEUTICS INC $917.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841673
Principal investigator 1 AKEBIA THERAPEUTICS INC $685.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841675
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841677
Principal investigator 1 AKEBIA THERAPEUTICS INC $801.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841679
Principal investigator 1 AKEBIA THERAPEUTICS INC $764.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841681
Principal investigator 1 AKEBIA THERAPEUTICS INC $764.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841683
Principal investigator 1 AKEBIA THERAPEUTICS INC $801.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841685
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842117
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842119
Principal investigator 1 AKEBIA THERAPEUTICS INC $764.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842121
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842123
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842125
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842361
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 12/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842363
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841547
Principal investigator 1 AKEBIA THERAPEUTICS INC $801.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841549
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841551
Principal investigator 1 AKEBIA THERAPEUTICS INC $764.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841553
Principal investigator 1 AKEBIA THERAPEUTICS INC $801.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841555
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841557
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841559
Principal investigator 1 AKEBIA THERAPEUTICS INC $801.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841615
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842011
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842487
Principal investigator 1 AKEBIA THERAPEUTICS INC $265.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842762
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842766
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842776
Principal investigator 1 AKEBIA THERAPEUTICS INC $265.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842816
Principal investigator 1 AKEBIA THERAPEUTICS INC $265.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842820
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842864
Principal investigator 1 AKEBIA THERAPEUTICS INC $265.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842872
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842874
Principal investigator 1 AKEBIA THERAPEUTICS INC $84.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843086
Principal investigator 1 AKEBIA THERAPEUTICS INC $354.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843088
Principal investigator 1 AKEBIA THERAPEUTICS INC $84.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843090
Principal investigator 1 AKEBIA THERAPEUTICS INC $354.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843092
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843230
Principal investigator 1 AKEBIA THERAPEUTICS INC $222.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843232
Principal investigator 1 AKEBIA THERAPEUTICS INC $30.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843234
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843236
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,189.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241845360
Principal investigator 1 AKEBIA THERAPEUTICS INC $290.00 11/05/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241845413
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841397
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841399
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841401
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841403
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841503
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841875
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841877
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842489
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842584
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842586
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842632
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842660
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842720
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842736
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843374
Principal investigator 1 AKEBIA THERAPEUTICS INC $222.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843376
Principal investigator 1 AKEBIA THERAPEUTICS INC $30.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843378
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843380
Principal investigator 1 AKEBIA THERAPEUTICS INC $410.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241845227
Principal investigator 1 AKEBIA THERAPEUTICS INC $100.00 10/03/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241845287
Principal investigator 1 AstraZeneca Pharmaceuticals LP $1,000.00 10/01/2025 Non-covered Recipient Entity
NEPHROLOGY AND HYPERTENSION ASSOCIATES, PC
Cardiovascular Renal and Metabolism Lokelma Hyperkalemia No dispute reported 06/30/2026 1185553399
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,432.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241841363
Principal investigator 1 AKEBIA THERAPEUTICS INC $338.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241842459
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843518
Principal investigator 1 AKEBIA THERAPEUTICS INC $222.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843520
Principal investigator 1 AKEBIA THERAPEUTICS INC $30.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843522
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843524
Principal investigator 1 AKEBIA THERAPEUTICS INC $3,690.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241845155
Principal investigator 1 AKEBIA THERAPEUTICS INC $900.00 09/10/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241845216
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843696
Principal investigator 1 AKEBIA THERAPEUTICS INC $222.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843699
Principal investigator 1 AKEBIA THERAPEUTICS INC $30.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843701
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843705
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843955
Principal investigator 1 AKEBIA THERAPEUTICS INC $222.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843958
Principal investigator 1 AKEBIA THERAPEUTICS INC $30.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843962
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241843967
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,476.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844941
Principal investigator 1 AKEBIA THERAPEUTICS INC $360.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844970
Principal investigator 1 AKEBIA THERAPEUTICS INC $4,387.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844982
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,070.00 08/06/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241845041
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844533
Principal investigator 1 AKEBIA THERAPEUTICS INC $222.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844537
Principal investigator 1 AKEBIA THERAPEUTICS INC $30.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844542
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844545
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844699
Principal investigator 1 AKEBIA THERAPEUTICS INC $222.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844702
Principal investigator 1 AKEBIA THERAPEUTICS INC $30.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844706
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844710
Principal investigator 1 AKEBIA THERAPEUTICS INC $600.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844713
Principal investigator 1 AKEBIA THERAPEUTICS INC $759.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844718
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,362.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844722
Principal investigator 1 AKEBIA THERAPEUTICS INC $912.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844726
Principal investigator 1 AKEBIA THERAPEUTICS INC $3,480.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844729
Principal investigator 1 AKEBIA THERAPEUTICS INC $360.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844733
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,767.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844737
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,435.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844865
Principal investigator 1 AKEBIA THERAPEUTICS INC $350.00 07/23/2025 Non-covered Recipient Entity
Greater Hartford Nephrology, LLC
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis No dispute reported 06/30/2026 1241844873